The specificity and sensitivity of fetal fibronectin testing are significantly lower for predicting delivery at less than 30 weeks gestation in asymptomatic women with cervical cerclage.
The specificity and sensitivity of fetal fibronectin (fFN) testing are significantly lower for predicting delivery at less than 30 weeks' gestation in asymptomatic women with cervical cerclage than they are in women without cerclage, according to a retrospective, observational study from London.
The study included 910 asymptomatic women at high risk for preterm birth who were referred to specialist antenatal clinics between the years 1997 and 2007 and who underwent fFN testing between 23 and 27 weeks' gestation.
Researchers calculated a specificity of 77% in women with cerclage in situ versus 90% in women without (P≤.00001) and a sensitivity of 60% in women who received the procedure versus 78.6% in women who did not (P>.4). The negative predictive value (NPV) of the fFN test, however, was greater than 98% in both groups.
Duhig KE, Chandiramani M, Seed PT, et al. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage. BJOG. 2009;116:799-803.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More